CTE — Cryosite Income Statement
0.000.00%
Last trade - 00:00
- AU$33.19m
- AU$29.62m
- AU$11.94m
- 97
- 40
- 36
- 60
2019 June 30th | 2020 June 30th | C2021 June 30th | R2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.97 | 9.01 | 10 | 11.8 | 11.9 |
Cost of Revenue | |||||
Gross Profit | 3.37 | 4.04 | 5.89 | 6.84 | 7.17 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.26 | 7.25 | 8.81 | 9.88 | 10.4 |
Operating Profit | -0.288 | 1.77 | 1.21 | 1.88 | 1.52 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.288 | 1.77 | 1.12 | 1.81 | 1.57 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.565 | 1.48 | 0.653 | 1.36 | 1.41 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.72 | 1.48 | 0.653 | 1.36 | 1.41 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.72 | 1.48 | 0.653 | 1.36 | 1.41 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.007 | 0.014 | 0.014 | 0.028 | 0.029 |
Dividends per Share |